NHI
Income statement / Annual
Last year (2023), National Health Investors, Inc.'s total revenue was $319.84 M,
an increase of 14.97% from the previous year.
In 2023, National Health Investors, Inc.'s net income was $135.65 M.
See National Health Investors, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$319.84 M
|
$278.19 M
|
$298.72 M
|
$332.81 M
|
$318.08 M
|
$294.61 M
|
$278.66 M
|
$248.50 M
|
$228.99 M
|
$177.51 M
|
| Cost of Revenue |
$11.51 M |
$9.79 M |
$11.64 M |
$9.65 M |
$5.80 M |
$1.17 M |
$960,000.00 |
$1.01 M |
$985,000.00 |
$620,000.00 |
| Gross Profit |
$308.32 M |
$268.41 M |
$287.08 M |
$323.16 M |
$312.28 M |
$293.45 M |
$277.70 M |
$247.49 M |
$228.00 M |
$176.89 M |
| Gross Profit Ratio |
0.96 |
0.96 |
0.96 |
0.97 |
0.98 |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$0.00
|
$0.23
|
$0.38
|
$0.57
|
$0.50
|
$0.52
|
$0.58
|
$0.65
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$19.72 M
|
$25.32 M
|
$19.34 M
|
$14.56 M
|
$13.91 M
|
$12.86 M
|
$12.71 M
|
$10.20 M
|
$10.98 M
|
$9.32 M
|
| Selling & Marketing
Expenses |
$100,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$19.82 M
|
$25.32 M
|
$19.34 M
|
$14.56 M
|
$13.91 M
|
$12.86 M
|
$12.71 M
|
$10.20 M
|
$10.98 M
|
$9.32 M
|
| Other Expenses |
$109.71 M |
$99.92 M |
$134.35 M |
$84.68 M |
$78.37 M |
$71.35 M |
$67.17 M |
$1.66 M |
$53.16 M |
$38.08 M |
| Operating Expenses |
$129.53 M |
$125.24 M |
$153.69 M |
$99.23 M |
$92.27 M |
$85.37 M |
$80.84 M |
$70.77 M |
$65.13 M |
$48.01 M |
| Cost And Expenses |
$141.04 M |
$135.03 M |
$165.33 M |
$108.88 M |
$98.07 M |
$85.37 M |
$80.84 M |
$70.77 M |
$65.13 M |
$48.01 M |
| Interest Income |
-$2.65 M |
$44.92 M |
$50.81 M |
$52.88 M |
$56.30 M |
$0.00 |
-$353,000.00 |
$18,000.00 |
-$18,000.00 |
-$4.73 M |
| Interest Expense |
$55.51 M |
$44.92 M |
$50.81 M |
$52.88 M |
$56.30 M |
$49.06 M |
$46.32 M |
$43.11 M |
$37.63 M |
$23.30 M |
| Depreciation &
Amortization |
$69.97 M
|
$140.03 M
|
$165.45 M
|
$106.65 M
|
$99.16 M
|
$89.79 M
|
$79.96 M
|
$86.12 M
|
$53.16 M
|
$40.69 M
|
| EBITDA |
$249.02 M
|
$151.99 M
|
$212.99 M
|
$303.95 M
|
$296.83 M
|
$280.59 M
|
$264.99 M
|
$236.08 M
|
$179.36 M
|
$167.06 M
|
| EBITDA Ratio |
0.78 |
0.55 |
0.71 |
0.91 |
0.93 |
0.95 |
0.95 |
0.95 |
0.94 |
0.93 |
| Operating Income Ratio
|
0.56
|
0.29
|
0.44
|
0.66
|
0.69
|
0.71
|
0.71
|
0.72
|
0.72
|
0.6
|
| Total Other
Income/Expenses Net |
-$44.41 M
|
-$80.22 M
|
-$15.04 M
|
-$33.54 M
|
-$59.56 M
|
-$49.94 M
|
-$38.45 M
|
-$74.13 M
|
-$66.10 M
|
-$26.44 M
|
| Income Before Tax |
$134.38 M |
$65.50 M |
$111.97 M |
$185.31 M |
$160.45 M |
$154.33 M |
$159.37 M |
$153.47 M |
$149.61 M |
$103.05 M |
| Income Before Tax Ratio
|
0.42
|
0.24
|
0.37
|
0.56
|
0.5
|
0.52
|
0.57
|
0.62
|
0.65
|
0.58
|
| Income Tax Expense |
$0.00 |
$42.44 M |
$49.78 M |
$49.94 M |
$56.29 M |
-$9.17 M |
$46.32 M |
$749,000.00 |
-$707,000.00 |
$24.67 M |
| Net Income |
$135.65 M |
$23.06 M |
$62.19 M |
$135.37 M |
$104.16 M |
$154.33 M |
$159.37 M |
$151.54 M |
$148.86 M |
$101.61 M |
| Net Income Ratio |
0.42 |
0.08 |
0.21 |
0.41 |
0.33 |
0.52 |
0.57 |
0.61 |
0.65 |
0.57 |
| EPS |
3.13 |
0.52 |
1.36 |
3.03 |
2.4 |
3.68 |
3.9 |
3.88 |
3.96 |
3.04 |
| EPS Diluted |
3.13 |
0.51 |
1.36 |
3.03 |
2.38 |
3.67 |
3.87 |
3.87 |
3.95 |
3.04 |
| Weighted Average Shares
Out |
$43.39 M
|
$44.77 M
|
$45.71 M
|
$44.70 M
|
$43.42 M
|
$41.94 M
|
$40.89 M
|
$39.01 M
|
$37.60 M
|
$33.38 M
|
| Weighted Average Shares
Out Diluted |
$43.39 M
|
$44.79 M
|
$45.73 M
|
$44.70 M
|
$43.70 M
|
$42.09 M
|
$41.15 M
|
$39.16 M
|
$37.64 M
|
$33.42 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
